Mylan Inc (MYL) 56.86 $MYL
Critical Alerts For Palo Alto Networks, Intrexon, FireEye, Mylan and Kite Pharma Released By InvestorsObserver
PR Newswire - Wed Jul 29, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PANW, XON, FEYE, MYL and KITE.
FEYE: 46.82 (+1.13), KITE: 70.07 (-1.84), XON: 60.03 (-0.57), MYL: 56.86 (+0.51), PANW: 183.03 (-3.80)
Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo
PR Newswire - Wed Jul 29, 6:00AM CDT
Mylan N.V. (NASDAQ: MYL) today announced that it received regulatory clearance from the European Commission under the European Union Merger Regulation (EUMR) for its proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE).
PRGO: 192.90 (+0.83), MYL: 56.86 (+0.51)
Teva to Buy Allergan's Generics Business for $40.5B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 5:13PM CDT
Allergan (AGN) has agreed to divest global generic pharmaceuticals business to Teva (TEVA) for $40.5 billion.
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55), AMAG: 64.40 (-1.83)
SuperValu and Pfizer are big market movers
AP - Tue Jul 28, 3:32PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RAI: 83.66 (-0.54), QSR.TO: 55.47 (+0.12), RJET: 5.12 (+1.68), SVU: 8.70 (+0.56), PFE: 35.67 (+0.32), IR: 61.67 (+0.97), MYL: 56.86 (+0.51), BECN: 35.61 (+2.02), MAS: 26.13 (+0.50), PGNX: 8.82 (-0.60), QSR: 43.05 (+0.30), TEVA: 70.86 (-0.55), WAB: 100.94 (+1.32), IPGP: 91.91 (+2.20)
Amgen Stock Clears Buy Point Ahead Of Earnings
at Investor's Business Daily - Tue Jul 28, 1:33PM CDT
A day after Teva Pharmaceuticals (TEVA) broke out of a base, fellow drugmaker Amgen (AMGN) is clearing a buy point. Amgen reports second quarter results after the close on Thursday. Earnings are projected to rise 3%, a slowdown from the first...
AGN: 336.72 (-2.78), BIIB: 309.64 (-10.29), SHPG: 265.85 (+2.60), MYL: 56.86 (+0.51), AMGN: 170.52 (-2.22), ABBV: 71.27 (+0.04), TEVA: 70.86 (-0.55)
Stocks In Rebound Mode; Icon, Cadence Break Out
at Investor's Business Daily - Tue Jul 28, 12:36PM CDT
Stocks stepped up rebound efforts and hit fresh session highs Tuesday afternoon. The major averages have recouped more than half of Monday's steep losses amid more earnings reports and mixed economic data. The S&P 500 led the pack with a 1% gain. On...
AGN: 336.72 (-2.78), BIDU: 168.27 (+0.24), MYL: 56.86 (+0.51), CDNS: 20.97 (+0.18), TEVA: 70.86 (-0.55), ICLR: 77.14 (+1.94)
Hikma Pharmaceuticals to Buy Generic Drug Maker Roxane for $2.65 Billion
at The Street - Tue Jul 28, 9:46AM CDT
Jordan's Hikma Pharmceuticals is set to become the sixth-largest U.S. generic drug maker after an agreement to buy Boehringer Ingelheim's Columbus, Ohio-based Roxane Laboratories for about $2.65 billion.
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
18.9% Return Seen to Date on SmarTrend Mylan Call (MYL)
Comtex SmarTrend(R) - Tue Jul 28, 9:40AM CDT
SmarTrend identified a Downtrend for Mylan (NASDAQ:MYL) on June 29th, 2015 at $68.16. In approximately 4 weeks, Mylan has returned 18.87% as of today's recent price of $55.29.
MYL: 56.86 (+0.51)
Business Highlights
By The Associated Press - AP - Mon Jul 27, 5:12PM CDT
___
AGN: 336.72 (-2.78), QSR: 43.05 (+0.30), F: 15.06 (+0.23), QSR.TO: 55.47 (+0.12), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55), MHFI: 100.29 (+1.89)
Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
at The Street - Mon Jul 27, 4:47PM CDT
Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
After Yesterday's Decline of 14.51%, Mylan Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 27, 3:46PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $55.40 to a high of $57.58. Yesterday, the shares fell 14.5%, which took the trading range below the 3-day low of $65.46 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 56.86 (+0.51)
SmarTrend Watching for Potential Rebound in Shares of Mylan After 14.51% Loss
Comtex SmarTrend(R) - Mon Jul 27, 3:45PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $55.40 to a high of $57.58. Yesterday, the shares fell 14.5%, which took the trading range below the 3-day low of $65.46 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 56.86 (+0.51)
Analysts expect more tie-ups in generic drug business
AP - Mon Jul 27, 3:43PM CDT
NEW YORK (AP) — Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
1 Comment
IPXL: 48.45 (-0.80), AGN: 336.72 (-2.78), AKRX: 46.10 (-0.91), SGNT: 25.49 (+0.02), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders
PR Newswire - Mon Jul 27, 2:58PM CDT
Mylan N.V. (NASDAQ: MYL) today announced that it will hold its extraordinary general meeting of shareholders in connection with its proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE) at the Okura Hotel Amsterdam on Friday, Aug. 28, 2015 at 1 p.m. Central European Time (CET).
PRGO: 192.90 (+0.83), MYL: 56.86 (+0.51)
Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.64 (-10.29), PRGO: 192.90 (+0.83), XOM: 82.51 (+0.03), MYL: 56.86 (+0.51), BMY: 64.49 (-0.17), AGN: 336.72 (-2.78), ISRG: 538.06 (-2.20), SBUX: 57.29 (+0.15), HCA: 93.57 (+1.28), IBM: 160.95 (+0.90), GM: 31.68 (+0.36), TEVA: 70.86 (-0.55), SPLK: 68.16 (-2.73), REGN: 542.66 (-9.79), NVS: 103.77 (+0.98)
3 Health Care Stocks to Trade for Gains
at The Street - Mon Jul 27, 12:56PM CDT
Here's a technical look at how to trade some of the most active stocks on the market right now.
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Why Mylan N.V. Stock Slumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 11:11AM CDT
What : Shares of the specialty and generic drugmaker Mylan fell by more than 14% today on heavy volume after Teva Pharmaceutical Industries Ltd. dropped its $40 billion hostile takeover bid. Instead, Teva has decided to pursue Allergan 's...
MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Why Teva Pharmaceutical Industries Ltd. Stock Jumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 10:04AM CDT
What : Shares of the generic drugmaker Teva Pharmaceutical Industries Ltd. rose by 11% in early morning trading after the company announced that it plans on buying Allergan 's generic drug business in a cash and stock deal worth a reported $40.5...
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Mylan (MYL) Stock Tanks After Teva Withdraws Takeover Bid
at The Street - Mon Jul 27, 8:55AM CDT
Mylan (MYL) shares are dropping after Teva Pharmaceuticals withdrew its unsolicited $40 billion takeover bid today.
MYL: 56.86 (+0.51)
Teva Confirms Allergan Generics Buy, Drops Mylan Bid
at Investor's Business Daily - Mon Jul 27, 8:10AM CDT
Teva Pharmaceutical (TEVA) confirmed reports Monday that it will buy Allergan's (AGN) generic drugs business for $40.5 billion and dropped its hostile takeover bid for Mylan Pharmaceuticals (MYL). Under the deal, Teva will pay $33.75 billion in cash...
AGN: 336.72 (-2.78), PRGO: 192.90 (+0.83), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Critical Alerts For Palo Alto Networks, Intrexon, FireEye, Mylan and Kite Pharma Released By InvestorsObserver
PR Newswire - Wed Jul 29, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PANW, XON, FEYE, MYL and KITE.
FEYE: 46.82 (+1.13), KITE: 70.07 (-1.84), XON: 60.03 (-0.57), MYL: 56.86 (+0.51), PANW: 183.03 (-3.80)
Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo
PR Newswire - Wed Jul 29, 6:00AM CDT
Mylan N.V. (NASDAQ: MYL) today announced that it received regulatory clearance from the European Commission under the European Union Merger Regulation (EUMR) for its proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE).
PRGO: 192.90 (+0.83), MYL: 56.86 (+0.51)
Teva to Buy Allergan's Generics Business for $40.5B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 5:13PM CDT
Allergan (AGN) has agreed to divest global generic pharmaceuticals business to Teva (TEVA) for $40.5 billion.
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55), AMAG: 64.40 (-1.83)
SuperValu and Pfizer are big market movers
AP - Tue Jul 28, 3:32PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RAI: 83.66 (-0.54), QSR.TO: 55.47 (+0.12), RJET: 5.12 (+1.68), SVU: 8.70 (+0.56), PFE: 35.67 (+0.32), IR: 61.67 (+0.97), MYL: 56.86 (+0.51), BECN: 35.61 (+2.02), MAS: 26.13 (+0.50), PGNX: 8.82 (-0.60), QSR: 43.05 (+0.30), TEVA: 70.86 (-0.55), WAB: 100.94 (+1.32), IPGP: 91.91 (+2.20)
Amgen Stock Clears Buy Point Ahead Of Earnings
at Investor's Business Daily - Tue Jul 28, 1:33PM CDT
A day after Teva Pharmaceuticals (TEVA) broke out of a base, fellow drugmaker Amgen (AMGN) is clearing a buy point. Amgen reports second quarter results after the close on Thursday. Earnings are projected to rise 3%, a slowdown from the first...
AGN: 336.72 (-2.78), BIIB: 309.64 (-10.29), SHPG: 265.85 (+2.60), MYL: 56.86 (+0.51), AMGN: 170.52 (-2.22), ABBV: 71.27 (+0.04), TEVA: 70.86 (-0.55)
Stocks In Rebound Mode; Icon, Cadence Break Out
at Investor's Business Daily - Tue Jul 28, 12:36PM CDT
Stocks stepped up rebound efforts and hit fresh session highs Tuesday afternoon. The major averages have recouped more than half of Monday's steep losses amid more earnings reports and mixed economic data. The S&P 500 led the pack with a 1% gain. On...
AGN: 336.72 (-2.78), BIDU: 168.27 (+0.24), MYL: 56.86 (+0.51), CDNS: 20.97 (+0.18), TEVA: 70.86 (-0.55), ICLR: 77.14 (+1.94)
Hikma Pharmaceuticals to Buy Generic Drug Maker Roxane for $2.65 Billion
at The Street - Tue Jul 28, 9:46AM CDT
Jordan's Hikma Pharmceuticals is set to become the sixth-largest U.S. generic drug maker after an agreement to buy Boehringer Ingelheim's Columbus, Ohio-based Roxane Laboratories for about $2.65 billion.
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
18.9% Return Seen to Date on SmarTrend Mylan Call (MYL)
Comtex SmarTrend(R) - Tue Jul 28, 9:40AM CDT
SmarTrend identified a Downtrend for Mylan (NASDAQ:MYL) on June 29th, 2015 at $68.16. In approximately 4 weeks, Mylan has returned 18.87% as of today's recent price of $55.29.
MYL: 56.86 (+0.51)
Business Highlights
By The Associated Press - AP - Mon Jul 27, 5:12PM CDT
___
AGN: 336.72 (-2.78), QSR: 43.05 (+0.30), F: 15.06 (+0.23), QSR.TO: 55.47 (+0.12), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55), MHFI: 100.29 (+1.89)
Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
at The Street - Mon Jul 27, 4:47PM CDT
Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
After Yesterday's Decline of 14.51%, Mylan Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 27, 3:46PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $55.40 to a high of $57.58. Yesterday, the shares fell 14.5%, which took the trading range below the 3-day low of $65.46 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 56.86 (+0.51)
SmarTrend Watching for Potential Rebound in Shares of Mylan After 14.51% Loss
Comtex SmarTrend(R) - Mon Jul 27, 3:45PM CDT
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $55.40 to a high of $57.58. Yesterday, the shares fell 14.5%, which took the trading range below the 3-day low of $65.46 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MYL: 56.86 (+0.51)
Analysts expect more tie-ups in generic drug business
AP - Mon Jul 27, 3:43PM CDT
NEW YORK (AP) — Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
1 Comment
IPXL: 48.45 (-0.80), AGN: 336.72 (-2.78), AKRX: 46.10 (-0.91), SGNT: 25.49 (+0.02), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders
PR Newswire - Mon Jul 27, 2:58PM CDT
Mylan N.V. (NASDAQ: MYL) today announced that it will hold its extraordinary general meeting of shareholders in connection with its proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE) at the Okura Hotel Amsterdam on Friday, Aug. 28, 2015 at 1 p.m. Central European Time (CET).
PRGO: 192.90 (+0.83), MYL: 56.86 (+0.51)
Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.64 (-10.29), PRGO: 192.90 (+0.83), XOM: 82.51 (+0.03), MYL: 56.86 (+0.51), BMY: 64.49 (-0.17), AGN: 336.72 (-2.78), ISRG: 538.06 (-2.20), SBUX: 57.29 (+0.15), HCA: 93.57 (+1.28), IBM: 160.95 (+0.90), GM: 31.68 (+0.36), TEVA: 70.86 (-0.55), SPLK: 68.16 (-2.73), REGN: 542.66 (-9.79), NVS: 103.77 (+0.98)
3 Health Care Stocks to Trade for Gains
at The Street - Mon Jul 27, 12:56PM CDT
Here's a technical look at how to trade some of the most active stocks on the market right now.
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Why Mylan N.V. Stock Slumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 11:11AM CDT
What : Shares of the specialty and generic drugmaker Mylan fell by more than 14% today on heavy volume after Teva Pharmaceutical Industries Ltd. dropped its $40 billion hostile takeover bid. Instead, Teva has decided to pursue Allergan 's...
MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Why Teva Pharmaceutical Industries Ltd. Stock Jumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 10:04AM CDT
What : Shares of the generic drugmaker Teva Pharmaceutical Industries Ltd. rose by 11% in early morning trading after the company announced that it plans on buying Allergan 's generic drug business in a cash and stock deal worth a reported $40.5...
AGN: 336.72 (-2.78), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
Mylan (MYL) Stock Tanks After Teva Withdraws Takeover Bid
at The Street - Mon Jul 27, 8:55AM CDT
Mylan (MYL) shares are dropping after Teva Pharmaceuticals withdrew its unsolicited $40 billion takeover bid today.
MYL: 56.86 (+0.51)
Teva Confirms Allergan Generics Buy, Drops Mylan Bid
at Investor's Business Daily - Mon Jul 27, 8:10AM CDT
Teva Pharmaceutical (TEVA) confirmed reports Monday that it will buy Allergan's (AGN) generic drugs business for $40.5 billion and dropped its hostile takeover bid for Mylan Pharmaceuticals (MYL). Under the deal, Teva will pay $33.75 billion in cash...
AGN: 336.72 (-2.78), PRGO: 192.90 (+0.83), MYL: 56.86 (+0.51), TEVA: 70.86 (-0.55)
